Last week in M&A was the best that 2023 has had to offer thus far. Wachtell, Lipton, Rosen & Katz and Sullivan & Cromwell led a $43 billion biotech deal, while Latham & Watkins, Shearman & Sterling and Freshfields, Bruckhaus & Derringer steered a $12.5 billion software deal.